Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexander Norbash

Neuroradiology Boston, MA Medical Doctor

NPI 1790752269 CMS profile 216596

88 E Newton St, Dept Radiology, Boston, MA 02118

Open in the dashboard

General payments

$76,560

88 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Norbash of Boston, MA is reported in the CMS Open Payments database as having received $76,560 across 88 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,750 6
2024 General $2,925 8
2023 General $12,711 11
2022 General $17,088 13
2021 General $8,529 16
2020 General $10,616 5
2019 General $18,940 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Norbash
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Alexander Norbash were reported at $5,750. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Alexander Norbash Neuroradiology median Middle half National median
2019 $18,940 $288 $71–$2,035 $163
2020 $10,616 $165 $32–$1,794 $114
2021 $8,529 $238 $42–$1,807 $132
2022 $17,088 $191 $49–$1,388 $149
2023 $12,711 $228 $56–$1,148 $160
2024 $2,925 $241 $97–$2,192 $164
2025 $5,750 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $25,136 43 payments
  2. Boston Scientific Corporation $16,349 3 payments
  3. Penumbra, Inc. $13,950 12 payments
  4. Siemens Medical Solutions USA, Inc. $12,056 19 payments
  5. Bayer Healthcare LLC $6,200 1 payment
  6. Ge Healthcare $2,429 4 payments
  7. Canon Medical Systems USA, Inc. $164 3 payments
  8. Canon Medical Systems Corporation $158 1 payment
  9. Covidien LP $118 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $46,786 57 payments
  2. Travel and Lodging $11,425 12 payments
  3. Acquisitions $9,274 2 payments
  4. Current or prospective ownership or investment interest $7,075 1 payment
  5. Food and Beverage $1,309 15 payments
  6. Grant $692 1 payment
Products named General payments · program years 2019–2025
  1. SURPASS EVOLVE $18,536 30 payments
  2. General - Therapies $13,107 2 payments
  3. Artemis Neurosurgery $5,625 3 payments
  4. Artemis Neurosurgery $4,950 6 payments
  5. Penumbra System $3,375 3 payments
  6. GENERAL THERAPIES $3,242 1 payment
  7. CITADEL $1,350 2 payments
  8. MAGNETOM Vida 3T $924 10 payments
  9. TARGET $675 1 payment
  10. ATLAS $675 1 payment
  11. Other $1,315 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record